| Tabs | tablets |
|---|---|
| CAP | camptodactyly-arthropathy-pericarditis [syndrome]; Canada Assistance Plan; capsule; captopril; catab... |
| CAPP | Captopril Prevention Project [study] |
| C | Captopril |
|---|---|
| CAP | Captopril |
| CP | Captopril |
| CPT | Captopril |
| captopril | <chemical> An orally active inhibitor of angiotensin I-converting enzyme. It reduces elevated blood pressure by inhibiting the renin-angiotensin system and also inhibits pressure responses to exogenous angiotensin I. Pharmacological action: angiotensin-converting enzyme inhibitors, antihypertensive agents. Chemical name: L-Proline, 1-(3-mercapto-2-methyl-1-oxopropyl)-, (S)- (12 Dec 1998) |
|---|---|
| captopril renal scan | <radiology> In a kidney with a lesion in the afferent arteriole (e.g. Atherosclerotic plaque), reflex constriction of the efferent arteriole occurs through angiotensin system thus maintaining renal perfusion. ACE inhibition prevents constriction of efferent arteriole. Therefore, perfusion is decreased to a kidney with afferent lesions and the renal scan to looks WORSE. Bottom line: renal scans appear WORSE with captopril administration if there is a lesion in the afferent arteriole. See: renal artery stenosis (12 Dec 1998) |
| tablets | Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (12 Dec 1998) |
| tablets, enteric-coated | Tablets coated with material that delays release of the medication until after they leave the stomach. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|